Skip to main content

Elevance Health, Inc.

corporate_fare Company Profile

Elevance Health, Inc.

ELV·NYSE·Finance·CIK 0001156039

Elevance Health is a leading health company focused on enhancing well-being and advancing health outcomes by delivering integrated health solutions. The company supports consumers with medical, pharmacy, and behavioral health services. Elevance Health is one of the largest health insurers in the United States, serving approximately 45.2 million medical members through its affiliated health plans as of December 31, 2025. The company offers a broad spectrum of network-based managed care risk-based plans to Individual, Employer Group, Medicaid, and Medicare markets. Additionally, Elevance Health provides managed care services to fee-based customers, including claims processing, stop loss insurance, care provider network access, medical management, care management, wellness programs, actuarial services, and other administrative services. Revenue is generated through risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through its Carelon businesses. Elevance Health provides services to the federal government through its Federal Health Products & Services business, which administers the Federal Employee Program ® (FEP ® ). The company also offers specialty services to both customers of its subsidiary health plans and unaffiliated health plans, including pharmacy services, stop loss insurance, dental, vision, and supplemental health insurance benefits, as well as integrated health services. Elevance Health is an independent licensee of the Blue Cross and Blue Shield Association.

Elevance Health, Inc. (NYSE:ELV) is a publicly traded company in the Finance sector. Wiseek monitors ELV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Elevance Health Reports Q1 GAAP EPS Decline and $935M Regulatory Accrual
  • Elevance Health Beats Q1 EPS, Raises Full-Year Guidance Despite $935M CMS Accrual
  • Elevance Health Beats Q1 Adjusted EPS by $1.78, Boosts Full-Year Guidance
  • Elevance Health Reaffirms FY2026 EPS Guidance of At Least $25.50, Including CMS Sanctions Impact
  • Elevance Health Reaffirms 2026 Earnings Guidance Despite Medicare Sanctions

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$199.13B
Net Income
$5.66B
Diluted EPS
$25.21
Op. Cash Flow
$4.29B
Free Cash Flow
$3.17B
Gross Profit
$177.95B
Operating Income
$7.2B
Cash & Equivalents
$9.49B
Total Debt
$31.9B
Debt / Equity
0.73×
Net Margin
2.8%
Shares Outstanding
220.72M sh
Source: 10-K · filed 2026-02-06 · accession 0001156039-26-000013
Browse all tickers starting with E →
$404.07
52-week range · as of 2026-04-22 $273.71 – $432.93
Market cap
$87.75B
Volume
1.6M (0.9× avg)
3-mo avg 1.7M
Live data · 2026-06-14 06:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELV - Latest Insights

ELV
Apr 22, 2026, 10:09 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $335.53
Real-time Price: $404.07 info
Change: +$68.54 (+20%) info
Market Cap: $87.749B info
ELV
Apr 22, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $404.07 info
Change: +$61.08 (+18%) info
Market Cap: $87.749B info
ELV
Apr 22, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $340.00
Real-time Price: $404.07 info
Change: +$64.07 (+19%) info
Market Cap: $87.749B info
ELV
Mar 10, 2026, 6:10 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $281.84
Real-time Price: $404.07 info
Change: +$122.23 (+43%) info
Market Cap: $87.749B info
ELV
Mar 10, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $281.84
Real-time Price: $404.07 info
Change: +$122.23 (+43%) info
Market Cap: $87.749B info
ELV
Mar 02, 2026, 6:13 AM EST
Source: Unknown
Importance Score:
8
Price at Filing: $310.05
Real-time Price: $404.07 info
Change: +$94.02 (+30%) info
Market Cap: $87.749B info
ELV
Mar 02, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $307.20
Real-time Price: $404.07 info
Change: +$96.87 (+32%) info
Market Cap: $87.749B info
ELV
Feb 26, 2026, 2:59 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $327.36
Real-time Price: $404.07 info
Change: +$76.71 (+23%) info
Market Cap: $87.749B info
ELV
Feb 06, 2026, 2:57 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $337.42
Real-time Price: $404.07 info
Change: +$66.65 (+20%) info
Market Cap: $87.749B info
ELV
Jan 28, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $312.33
Real-time Price: $404.07 info
Change: +$91.74 (+29%) info
Market Cap: $87.749B info